Home>News>Economy>Pharmaceutical company shares have increased for more than 500% after COVID-19 drug test

Pharmaceutical company shares have increased for more than 500% after COVID-19 drug test

Pharmaceutical company shares have increased for more than 500% after COVID-19 drug test

According to the London Stock Exchange, at 14:30 Moscow time, shares of the British pharmaceutical company Synairgen rose by 535.62% compared to the price at the close of trading on Friday.

The shares increased after the company announced testing of its experimental drug, SNG001. On Monday, it became known that medication reduced the risk of complications from COVID-19.

About 220 people took part in the clinical testing. Thanks to the drug, it was possible to reduce the risk of switching to respiratory care and the risk of death was reduced by 79% compared to those who received a placebo. Those who received the medicine also showed a greater chance of complete recovery.

SNG001 is taken internally through the respiratory tract. It is created using interferon beta, a naturally occurring protein. Scientists managed to find out that patients who are sick or those most vulnerable to coronavirus often have interferon deficiency. Among them were elderly patients, as well as people with heart disease, lung disease or diabetes.

The pharmaceutical company was founded by three professors from the University of Southampton. The company’s shares have increased in value by 3850% for the entire current year. They are traded on the platform for emerging organizations of the London Stock Exchange. FinnCap analyst Mark Brewer said that if the drug goes to market, the company will be the subject of discussions with regulators.


Актуальные новости

29.12.2021, 06:34
Sector ETFs For Exposure To Industrials And Information Technology Stocks
11.06.2021, 02:49
Bitcoin 2021 attendees’ positive COVID-19 tests are going viral
19.06.2022, 12:05
1 Stock To Buy, 1 To Dump When Markets Open: Dollar General, MicroStrategy
06.10.2021, 13:31
3 Solid Dividend Stocks To Stash In Your Retirement Income Portfolio
26.11.2021, 04:46
WHO to assess new highly mutated Covid-19 variant as countries ramp up health checks
10.06.2021, 09:08
With Interest Rates Low, 2 ETFs To Boost Income
16.04.2022, 13:48
Biggest Movers: WAVES, GMT, and EOS Among Big Gainers on Easter Weekend
25.01.2022, 20:00
Technical Analysis: Meme Coins, Avalanche Move Higher on Tuesday
$ 20276
$ 1143.37
$ 1
$ 0.337388
$ 52.69